Literature DB >> 26850596

The effect of antisense inhibitor of miRNA 106b∼25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell.

Rupeng Zhang1,2, Fangxuan Li3, Weijia Wang4, Xuejun Wang4, Shixia Li3, Juntian Liu5,6.   

Abstract

Accumulating data has demonstrated that miRNA 106b∼25, which are composed of the highly conserved miRNA 106b, miRNA 93, and miRNA 25, play carcinogenic roles in cancers. We investigated the expression of miRNA 106b∼25 in gastric cancer cells (SGC 7901, MGC 803, BGC 823) and normal gastric epithelial cell then inhibited miRNA 106b∼25 expression via transiently transfecting their antisense inhibitor. After miRNA 106b∼25 cluster was inhibited, MTT, Scratch test, Transwell invasion test, and flow cytometry were applied to investigate the proliferation, invasion, migration, cell cycle, and apoptosis of gastric cancer cell. The expression of miRNA 106b, miRNA 93, and miRNA 25 in gastric cancer cells SGC 7901, MGC 803, and BGC 823 was significantly higher than in gastric epithelial cell GES-1. The most significant suppression of miRNA 106b∼25 expressions can be detected in MGC 803 cell after transiently transfecting their antisense inhibitors. So, MGC 803 cell was selected as our research object. After inhibiting miRNA 106b and miRNA 93 respectively and combined, the proliferation, migration, and invasion of gastric cancer cell MGC 803 were significantly suppressed. The most significant suppression was observed in combined inhibiting group. After miRNA 106b∼25 cluster was inhibited respectively or combined, more gastric cancer cells were arrested in the G0G1 phase. However, there was no statistical difference in comparing with control groups. While the percentages of apoptotic cells increased after miRNA 106b∼25 cluster was inhibited, the statistical difference was detected only in combined inhibiting group. Inhibiting miRNA 106b∼25 cluster via transfecting antisense inhibitor can influence biological behavior of gastric cancer cell.

Entities:  

Keywords:  Antisense inhibitors; Biological behavior; Gastric cancer; miRNA 106b; miRNA 25; miRNA 93

Mesh:

Substances:

Year:  2016        PMID: 26850596     DOI: 10.1007/s13277-016-4937-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.

Authors:  Laura Poliseno; Leonardo Salmena; Luisa Riccardi; Alessandro Fornari; Min Sup Song; Robin M Hobbs; Paolo Sportoletti; Shorheh Varmeh; Ainara Egia; Giuseppe Fedele; Lucia Rameh; Massimo Loda; Pier Paolo Pandolfi
Journal:  Sci Signal       Date:  2010-04-13       Impact factor: 8.192

3.  E2F1 is crucial for E2F-dependent apoptosis.

Authors:  Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

4.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

Review 5.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

6.  MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers.

Authors:  Rupeng Zhang; Weijia Wang; Fangxuan Li; Hui Zhang; Juntian Liu
Journal:  Med Oncol       Date:  2014-09-14       Impact factor: 3.064

7.  A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma.

Authors:  Yao Liu; Yixin Zhang; Juan Wen; Li Liu; Xiangjun Zhai; Jibin Liu; Shandong Pan; Jianguo Chen; Hongbing Shen; Zhibin Hu
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Perk-dependent repression of miR-106b-25 cluster is required for ER stress-induced apoptosis.

Authors:  S Gupta; D E Read; A Deepti; K Cawley; A Gupta; D Oommen; T Verfaillie; S Matus; M A Smith; J L Mott; P Agostinis; C Hetz; A Samali
Journal:  Cell Death Dis       Date:  2012-06-28       Impact factor: 8.469

9.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

10.  MiR-93 enhances angiogenesis and metastasis by targeting LATS2.

Authors:  Ling Fang; William W Du; Weining Yang; Zina Jeyapalan Rutnam; Chun Peng; Haoran Li; Yunxia Q O'Malley; Ryan W Askeland; Sonia Sugg; Mingyao Liu; Tanvi Mehta; Zhaoqun Deng; Burton B Yang
Journal:  Cell Cycle       Date:  2012-10-30       Impact factor: 4.534

View more
  9 in total

1.  Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.

Authors:  Xinyi Wang; Haiyang Zhang; Ming Bai; Tao Ning; Shaohua Ge; Ting Deng; Rui Liu; Le Zhang; Guoguang Ying; Yi Ba
Journal:  Mol Ther       Date:  2018-01-08       Impact factor: 11.454

2.  Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer.

Authors:  Rupeng Zhang; Yuenan Guo; Zhenchi Ma; Gang Ma; Qiang Xue; Fangxuan Li; Liren Liu
Journal:  Oncotarget       Date:  2017-04-18

3.  The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L.

Authors:  A L Guarnieri; C G Towers; D J Drasin; M U J Oliphant; Z Andrysik; T J Hotz; R L Vartuli; E S Linklater; A Pandey; S Khanal; J M Espinosa; H L Ford
Journal:  Oncogene       Date:  2018-04-17       Impact factor: 9.867

Review 4.  Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.

Authors:  Svetlana Miroshnichenko; Olga Patutina
Journal:  Front Pharmacol       Date:  2019-05-16       Impact factor: 5.988

5.  Targeting ZEB2 By microRNA-129 In Non-Small Cell Lung Cancer Suppresses Cell Proliferation, Invasion And Migration Via Regulating Wnt/β-Catenin Signaling Pathway And Epithelial-Mesenchymal Transition.

Authors:  Xingtao Li; Chunhong Li; Hongmei Bi; Shufang Bai; Lin Zhao; Jing Zhang; Chunhui Qi
Journal:  Onco Targets Ther       Date:  2019-11-05       Impact factor: 4.147

6.  The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.

Authors:  Fangxuan Li; Yuenan Guo; Juntian Liu; Rupeng Zhang
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

7.  MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell proliferation synergistically.

Authors:  Kate Hua; Yu-Ting Chen; Chian-Feng Chen; Ya-Syuan Tang; Tzu-Ting Huang; Yu-Cheng Lin; Tien-Shun Yeh; Kuo-Hung Huang; Hsin-Chen Lee; Ming-Ta Hsu; Chin-Wen Chi; Chew-Wun Wu; Chi-Hung Lin; Yueh-Hsin Ping
Journal:  Oncol Lett       Date:  2018-06-07       Impact factor: 2.967

8.  Tumor promoter role of miR‑647 in gastric cancer via repression of TP73.

Authors:  Xiangqian Zhang; Min Zhang; Guifeng Wang; Ye Tian; Xiaolong He
Journal:  Mol Med Rep       Date:  2018-08-06       Impact factor: 2.952

9.  Multivariate analysis of clinicopathological and prognostic significance of miRNA 106b~25 cluster in gastric cancer.

Authors:  Fangxuan Li; Jinchao Huang; Juntian Liu; Wengui Xu; Zhiyong Yuan
Journal:  Cancer Cell Int       Date:  2019-07-29       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.